These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30064129)

  • 21. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
    Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.
    Bejarano J; Navarro-Marquez M; Morales-Zavala F; Morales JO; Garcia-Carvajal I; Araya-Fuentes E; Flores Y; Verdejo HE; Castro PF; Lavandero S; Kogan MJ
    Theranostics; 2018; 8(17):4710-4732. PubMed ID: 30279733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality Imaging Agents with PET as the Fundamental Pillar.
    Ni D; Ehlerding EB; Cai W
    Angew Chem Int Ed Engl; 2019 Feb; 58(9):2570-2579. PubMed ID: 29968300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoimaging in cardiovascular diseases: Current state of the art.
    Deb S; Ghosh K; Shetty SD
    Indian J Med Res; 2015 Mar; 141(3):285-98. PubMed ID: 25963489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
    Wickline SA; Neubauer AM; Winter PM; Caruthers SD; Lanza GM
    J Magn Reson Imaging; 2007 Apr; 25(4):667-80. PubMed ID: 17347992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality nanotracers for cardiovascular applications.
    Mulder WJ; Cormode DP; Hak S; Lobatto ME; Silvera S; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S103-11. PubMed ID: 18641599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of Multimodal Neuroimaging Using Nanoprobes.
    Sridhar S; Mishra S; Gulyás M; Padmanabhan P; Gulyás B
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Imaging of the Heart.
    Boutagy NE; Feher A; Alkhalil I; Umoh N; Sinusas AJ
    Compr Physiol; 2019 Mar; 9(2):477-533. PubMed ID: 30873600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging.
    Sun Y; Zhu X; Peng J; Li F
    ACS Nano; 2013 Dec; 7(12):11290-300. PubMed ID: 24205939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
    Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
    Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).
    Rudd JH; Myers KS; Sanz J; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):379-88. PubMed ID: 18025992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging.
    Furer V; Fayad ZA; Mani V; Calcagno C; Farkouh ME; Greenberg JD
    Semin Arthritis Rheum; 2012 Apr; 41(5):676-88. PubMed ID: 22000818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticles for molecular imaging--an overview.
    Minchin RF; Martin DJ
    Endocrinology; 2010 Feb; 151(2):474-81. PubMed ID: 20016027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular imaging by cardiovascular MR.
    Cyrus T; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted multimodal imaging modalities.
    Lee SY; Jeon SI; Jung S; Chung IJ; Ahn CH
    Adv Drug Deliv Rev; 2014 Sep; 76():60-78. PubMed ID: 25064554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives.
    Niccoli Asabella A; Di Palo A; Altini C; Ferrari C; Rubini G
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issue "noninvasive molecular imaging and theranostic probes": New concepts in myocardial imaging.
    Bengel FM
    Methods; 2017 Nov; 130():72-78. PubMed ID: 28576327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes.
    Stendahl JC; Sinusas AJ
    J Nucl Med; 2015 Nov; 56(11):1637-41. PubMed ID: 26294304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory medicine for molecular imaging of atherosclerosis.
    Mangge H; Almer G; Stelzer I; Reininghaus E; Prassl R
    Clin Chim Acta; 2014 Nov; 437():19-24. PubMed ID: 25003647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.